bHLH-PAS proteins in cancer
The DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.
Abstract
Mammalian basic HLH (helix-loop-helix)-PER-ARNT-SIM (bHLH-PAS) proteins are heterodimeric transcription factors that sense and respond to environmental signals (such as pollutants) or to physiological signals (for example, hypoxia and circadian rhythms) through their two PAS domains. PAS domains form a generic three-dimensional fold, which commonly contains an internal cavity capable of small-molecule binding and outer surfaces adept at protein-protein interactions. These proteins are important in several pro-tumour and antitumour pathways and their activities can be modulated by both natural metabolites and oncometabolites. Recently determined structures and successful small-molecule screening programmes are now providing new opportunities to discover selective agonists and antagonists directed against this multitasking family of transcription factors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Each HIF transcription factor is composed of two subunits: the α-subunit and the β-subunit, both of which belong to the basic helix-loop-helix (HLH)-PER-ARNT-SIM (bHLH-PAS) protein family (Bersten et al., 2013).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Bersten et al., 2013
In the citing paper
“The reliability of the model derived from this template is supported by the observation that the PAS fold is highly conserved, especially among the bHLH-PAS proteins which also share functional similarities2,33 (RMSD on Cα lower than 2 Å even between PAS domain pairs with 20–30% identity).”
From Modeling the binding of diverse ligands within the Ah receptor ligand binding domain (2019) · cites this paper as [2]
Citations
Cites
1 retracted
RETRACTED: Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization
Lee, K., Zhang, H., Qian, D. Z., Rey, S., Liu, J. O., & Semenza, G. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909353106 · Cited by 451
RetractedThe Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Integrative Genomic Profiling of Human Prostate Cancer
Taylor, B. S., Schultz, N., Hieronymus, H., Gopalan, A., Xiao, Y., Carver, B. S., Arora, V. K., Kaushik, P., Cerami, E., Reva, B., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.05.026 · Cited by 3,701
Hypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Cited by
Items 101–200 of 301
Yang, T., Yuan, P., Yang, Y., Liang, N. N., Wang, Q., Li, J., Lu, R., Zhang, H., Mu, J., Yan, Z., et al. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.10.025 · Cited by 25
E-box binding transcription factors in cancer
Pan, Y., van der Watt, P. J., & Kay, S. A. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1223208 · Cited by 25
Halawani, D., Wang, Y., Ramakrishnan, A., Estill, M. S., He, X., Shen, L., Friedel, R. H., & Zou, H. (2023) · Nature Communications · doi:10.1038/s41467-023-40816-7 · Cited by 26
Kim, H.-M., Kim, J., Choi, Y., Chun, H., Im, I., Han, Y., Song, C., Yoon, S., & Park, H. (2016) · Scientific Reports · doi:10.1038/srep21684 · Cited by 25
Ligand-induced perturbation of the HIF-2α:ARNT dimer dynamics
Motta, S., Minici, C., Corrada, D., Bonati, L., & Pandini, A. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006021 · Cited by 25
Metadynamics-Based Approaches for Modeling the Hypoxia-Inducible Factor 2α Ligand Binding Process
Callea, L., Bonati, L., & Motta, S. (2021) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.1c00114 · Cited by 25
Chitrala, K. N., Yang, X., Nagarkatti, P. S., & Nagarkatti, M. (2018) · BMC Structural Biology · doi:10.1186/s12900-018-0095-2 · Cited by 25
Corrada, D., Denison, M. S., & Bonati, L. (2017) · Molecular BioSystems · doi:10.1039/c7mb00005g · Cited by 24
HAND2-mediated proteolysis negatively regulates the function of estrogen receptor α
Fukuda, T., Shirane, A., Wada‐Hiraike, O., Oda, K., Tanikawa, M., SAKUABASHI, A., Hirano, M., Fu, H., Morita, Y., Miyamoto, Y., et al. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4070 · Cited by 24
A novel isoform of ATOH8 promotes the metastasis of breast cancer by regulating RhoC
Xu, M., HUANG, S. H., Dong, X., Chen, Y., Li, M., Shi, W., Wang, G., Huang, C., Wang, Q., Liu, Y., et al. (2020) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaa050 · Cited by 24
Circadian rhythm disruption and endocrine-related tumors
Savvidis, C., Kallistrou, E., Kouroglou, E., Dionysopoulou, S., Gavriiloglou, G., Ragia, D., Tsiama, V., Proikaki, S., Belis, K., & Ilias, Ι. (2024) · World Journal of Clinical Oncology · doi:10.5306/wjco.v15.i7.818 · Cited by 24
All-encomPASsing regulation of β-cells: PAS domain proteins in β-cell dysfunction and diabetes
Sabatini, P. V., & Lynn, F. C. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.11.002 · Cited by 24
The aryl hydrocarbon receptor as a model PAS sensor
Vazquez-Rivera, E., Rojas, B. L., Parrott, J. C., Shen, A. L., Xing, Y., Carney, P. R., & Bradfield, C. A. (2021) · Toxicology Reports · doi:10.1016/j.toxrep.2021.11.017 · Cited by 24
Vogeley, C., Rolfes, K. M., Krutmann, J., & Haarmann‐Stemmann, T. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.841721 · Cited by 24
LXXLL Peptide Converts Transportan 10 to a Potent Inducer of Apoptosis in Breast Cancer Cells
Tints, K., Prink, M., Neuman, T., & Palm, K. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15045680 · Cited by 24
The Complex Biology of the Aryl Hydrocarbon Receptor and Its Role in the Pituitary Gland
Formosa, R., & Vassallo, J. (2017) · Hormones and Cancer · doi:10.1007/s12672-017-0300-y · Cited by 25
Pearson, S. J., Sarkar, T. R., McQueen, C. M., Epps, J. L., Schmitt, E. E., Wall, S. W., Scribner, K. C., Wyatt, G. L., Barhoumi, R., Behbod, F., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0622-4 · Cited by 24
Targeting Endothelial HIF2α/ARNT Expression for Ischemic Heart Disease Therapy
Ullah, K., Ai, L., Humayun, Z., & Wu, R. (2023) · Biology · doi:10.3390/biology12070995 · Cited by 23
Genetic variants in ultraconserved regions associate with prostate cancer recurrence and survival
Bao, B., Lin, V. C.-H., Yu, C., Yin, H., Chang, T.-Y., Lu, T., Lee, H., Pao, J.-B., Huang, C., & Huang, S. (2016) · Scientific Reports · doi:10.1038/srep22124 · Cited by 23
Gardella, K. A., Muro, I., Fang, G., Sarkar, K., Méndez-Solís, O., & Wright, C. W. (2016) · Oncotarget · doi:10.18632/oncotarget.7539 · Cited by 23
Research progress on circadian clock genes in common abdominal malignant tumors (Review)
Yang, S., Ren, Q., Wen, L., Hu, J., & Wang, H. (2017) · Oncology Letters · doi:10.3892/ol.2017.6856 · Cited by 23
ARNT2 is downregulated and serves as a potential tumor suppressor gene in non-small cell lung cancer
Yang, B., Yang, E., Liao, H., Wang, Z., Den, Z., & Ren, H. (2015) · Tumor Biology · doi:10.1007/s13277-014-2820-1 · Cited by 23
Hypoxic State of Cells and Immunosenescence: A Focus on the Role of the HIF Signaling Pathway
Troise, D. E., Infante, B., Mercuri, S., Netti, G. S., Ranieri, E., Gesualdo, L., Stallone, G., & Pontrelli, P. (2023) · Biomedicines · doi:10.3390/biomedicines11082163 · Cited by 22
PITX1, a specificity determinant in the HIF-1α-mediated transcriptional response to hypoxia
Mudie, S., Bandarra, D., Batie, M., Biddlestone, J., Moniz, S., Ortmann, B. M., Shmakova, A., & Rocha, S. (2014) · Cell Cycle · doi:10.4161/15384101.2014.972889 · Cited by 22
Jia, Y., Hao, S.-H., Jin, G., Li, H., Ma, X., Zheng, Y., Xiao, D., & Wang, Y. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3376-y · Cited by 22
Tamaoki, M., Komatsuzaki, R., Komatsu, M., Minashi, K., Aoyagi, K., Nishimura, T., Chiwaki, F., Hiroki, T., Daiko, H., Morishita, K., et al. (2018) · Cancer Science · doi:10.1111/cas.13531 · Cited by 22
Khan, F. A., Fouad, D., Ataya, F. S., Fang, N., Dong, J., & Ji, S. (2024) · Biology Direct · doi:10.1186/s13062-024-00553-3 · Cited by 21
Cross-regulatory Circuit Between AHR and Microbiota
Ji, J., & Qu, H. (2018) · Current Drug Metabolism · doi:10.2174/1389200219666180129151150 · Cited by 21
The Aryl Hydrocarbon Receptor, Epigenetics and the Aging Process
Abudahab, S., Price, E. T., Dozmorov, M. G., Deshpande, L. S., & McClay, J. L. (2023) · The journal of nutrition health & aging · doi:10.1007/s12603-023-1908-1 · Cited by 23
ARNT is a potential direct HIF-1 target gene in human Hep3B hepatocellular carcinoma cells
Mandl, M., & Depping, R. (2017) · Cancer Cell International · doi:10.1186/s12935-017-0446-2 · Cited by 21
In vitro toxicity and in silico docking analysis of two novel selective AH-receptor modulators
Mahiout, S., Tagliabue, S. G., Nasri, A., Omoruyi, I. M., Pettersson, L., Bonati, L., & Pohjanvirta, R. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.06.010 · Cited by 19
Wolff, D. W., Deng, Z., Bianchi, A., Foley, C. E., Han, Z., Wang, X., Shen, S., Rosenberg, M. M., Moparthy, S., Yun, D. H., et al. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2022.01.007 · Cited by 19
Liu, X., Liu, S., Tang, Y., Pu, Z., Xiao, H., Gao, J., Yin, Q., Jia, Y., & Bai, Q. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03293-2 · Cited by 18
Intermittent Hypoxia Alters the Circadian Expression of Clock Genes in Mouse Brain and Liver
Koritala, B. S. C., Lee, Y. Y., Bhadri, S. S., Gaspar, L. S., Stanforth, C., Wu, G., Ruben, M. D., Francey, L. J., & Smith, D. F. (2021) · Genes · doi:10.3390/genes12101627 · Cited by 18
Ma, X., Cheng, M., Jia, Y., Zhang, K., Zhang, H., Feng, D., Xu, W., & Qiao, G. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02603-9 · Cited by 17
Yazdani, B., Sirous, H., Enguita, F. J., Brogi, S., Wing, P. A. C., & Fassihi, A. (2023) · Molecular Diversity · doi:10.1007/s11030-023-10650-6 · Cited by 17
Tumova, S., Doležel, D., & Jindra, M. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168332 · Cited by 17
Li, Y., Yu, X., Shi, J., Zhao, J., & Li, L. (2024) · Placenta · doi:10.1016/j.placenta.2024.05.134 · Cited by 17
Huang, J., Wang, Y., & Zhou, Y. (2022) · RSC Advances · doi:10.1039/d2ra00622g · Cited by 17
Hypoxia signaling pathway: A central mediator in endocrine tumors
Watts, D., Jaykar, M. T., Bechmann, N., & Wielockx, B. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1103075 · Cited by 17
Multi-level interaction between HIF and AHR transcriptional pathways in kidney carcinoma
Lafleur, V. N., Halim, S., Choudhry, H., Ratcliffe, P. J., & Mole, D. R. (2023) · Life Science Alliance · doi:10.26508/lsa.202201756 · Cited by 17
Zhang, Y., Jiang, L., Qin, N., Cao, M., Liang, X., & Wang, R. (2020) · Biochemistry and Cell Biology · doi:10.1139/bcb-2020-0090 · Cited by 17
The signaling pathway of hypoxia inducible factor in regulating gut homeostasis
Liu, W., Fan, X., Jian, B., Wen, D., Wang, H., Liu, Z., & Li, B. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1289102 · Cited by 16
Current knowledge of ferroptosis in the pathogenesis and prognosis of oral squamous cell carcinoma
Zhou, L., Wu, Y., Ying, Y., & Ding, Y. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111176 · Cited by 16
Bourner, L. A., Muro, I., Cooper, A. M., Choudhury, B. K., Bailey, A. O., Russell, W. K., Khanipov, K., Golovko, G., & Wright, C. W. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2114336119 · Cited by 16
TCDD-Induced Allosteric Perturbation of the AhR:ARNT Binding to DNA
Motta, S., & Bonati, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119339 · Cited by 16
Leclair, H. M., Tardif, N., Paris, A., Galibert, M., & Corre, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145025 · Cited by 16
Control of lymphocyte homeostasis and effector function by the aryl hydrocarbon receptor
Wang, H., Wei, Y., & Yu, D. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.03.046 · Cited by 16
HIF-1α and BMAL1 in bone regeneration: crosstalk between hypoxia response and circadian rhythm
Weng, Y., Xiong, J., Zhao, Q., & Tan, Z. (2026) · Bone Research · doi:10.1038/s41413-026-00506-8 · Cited by 16
AhR inhibition promotes axon regeneration via a stress–growth switch
Halawani, D., Wang, Y., Li, J., Halperin, D. S., Ni, H., Estill, M. S., Ramakrishnan, A., Shen, L., Sefiani, A., Geoffroy, C. G., et al. (2026) · Nature · doi:10.1038/s41586-026-10295-z · Cited by 15
The circadian clock regulates rhythmic erythropoietin expression in the murine kidney
Sciesielski, L. K., Felten, M., Michalick, L., Kirschner, K. M., Lattanzi, G., Jacobi, C., Wallach, T. E., Lang, V., Landgraf, D., Kramer, A., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.07.012 · Cited by 15
Mutz, C., Schwentner, R., Kauer, M. O., Katschnig, A. M., Kromp, F., Aryee, D. N. T., Erhardt, S., Goiny, M., Alonso, J., Fuchs, D., et al. (2016) · FEBS Letters · doi:10.1002/1873-3468.12243 · Cited by 15
Genetic modification of hypoxia signaling in animal models and its effect on cancer
García-Heredia, J. M., Felipe‐Abrio, B., Cano, D. A., & Carnero, A. (2014) · Clinical & Translational Oncology · doi:10.1007/s12094-014-1236-0 · Cited by 15
AHR is a tunable knob that controls HTLV-1 latency-reactivation switching
Hong, W., Cheng, W., Zheng, T., Jiang, N., & Xu, R. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008664 · Cited by 14
Nor, W., Chung, I., & Said, N. A. B. M. (2020) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504020x16037933185170 · Cited by 14
Nguyen, B. D., Stevens, B. L., Elson, D. J., Finlay, D., Gamble, J. T., Kopparapu, P., Tanguay, R. L., Buermeyer, A. B., Kerkvliet, N. I., & Kolluri, S. K. (2022) · FEBS Journal · doi:10.1111/febs.16683 · Cited by 14
Takashima, K., Fujii, S., Komatsuzaki, R., Komatsu, M., Takahashi, M., Kojima, T., Daiko, H., Minashi, K., Chiwaki, F., Muto, M., et al. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.4963 · Cited by 14
Hou, P., Yao, Y., Wu, Y., Yu, H., Qin, Y., Yi, L., & Mi, M. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1500293 · Cited by 13
Chakraborty, P., Ghatak, S., Chenkual, S., Pachuau, L., Zohmingthanga, J., Bawihtlung, Z., Khenglawt, L., Pautu, J. L., Maitra, A., Chhakchhuak, L., et al. (2021) · Genes and Environment · doi:10.1186/s41021-021-00174-6 · Cited by 13
Feng, J., Zhu, L., He, C., Xiang, R., Liu, J., Cai, J., & Wang, D. (2025) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-025-01181-1 · Cited by 12
Hypoxia effects on cancer stem cell phenotype in colorectal cancer: a mini-review
Rainho, M. D. A., Mencalha, A. L., & Thole, A. A. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06809-9 · Cited by 12
Chen, C., Wang, Z., Liao, Z., Zhang, Y., Lei, W., & Shui, X. (2023) · Molecular Medicine Reports · doi:10.3892/mmr.2023.13134 · Cited by 12
HIF-α factors as potential therapeutic targets in leukemia
Magliulo, D., & Bernardi, R. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1538357 · Cited by 12
Nakamura, K., Komatsu, M., Chiwaki, F., Takeda, T., Kobayashi, Y., Banno, K., Aoki, D., Yoshida, T., & Sasaki, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-15261-4 · Cited by 12
Hypoxia Signaling and Circadian Disruption in and by Pheochromocytoma
Tabebi, M., Söderkvist, P., & Jensen, L. D. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00612 · Cited by 12
Identification of small-molecule ligand-binding sites on and in the ARNT PAS-B domain
Xu, X., Closson, J. D., Marcelino, L. P., Favaro, D. C., Silvestrini, M., Solazzo, R., Chong, L. T., & Gardner, K. H. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107606 · Cited by 11
A viable hypomorphic Arnt2 mutation causes hyperphagic obesity, diabetes and hepatic steatosis
Turer, E. E., Miguel, M. S., Wang, K.-W., McAlpine, W., Ou, F., Li, X., Tang, M., Zang, Z., Wang, J., Hayse, B., et al. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.035451 · Cited by 11
Direct inhibition of tumor hypoxia response with synthetic transcriptional repressors
Qiao, Z., Nguyen, L. C., Yang, D., Dann, C., Thomas, D. M., Henn, M. A., Valdespino, A., Swenson, C., Oakes, S. A., Rosner, M. R., et al. (2024) · Nature Chemical Biology · doi:10.1038/s41589-024-01716-z · Cited by 11
PER3 suppresses tumor metastasis of oral squamous cell carcinoma by promoting HIF-1α degradation
Li, Y., Li, B., Yang, K., Zhu, L., Tang, H., Huang, Y., Deng, J., & Duan, J. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102258 · Cited by 11
Scott, C., Stokes, R., Cha, K. M., Clouston, A. D., Eslam, M., Metwally, M., Swarbrick, M. M., George, J., & Gunton, J. E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225332 · Cited by 11
Kim, J., Im, I., Kim, H., Jeon, J. S., Kang, E., Jo, S., Chun, H., Yoon, S., Kim, J., Kim, S. K., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201903110r · Cited by 11
Bersten, D. C., Sullivan, A. E., Li, D., Bhakti, V. L. D., Bent, S. J., & Whitelaw, M. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116373 · Cited by 11
Self-citationNayak, R. C., Chang, K. H., Singh, A. K., Kotliar, M., Desai, M., Wellendorf, A. M., Wunderlich, M., Bartram, J. L., Mizukawa, B. E., Cuadrado, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30651-7 · Cited by 11
Sullivan, A. E., Raimondo, A., Schwab, T. A., Bruning, J. B., Froguel, P., Farooqi, I. S., Peet, D. J., & Whitelaw, M. L. (2014) · Biochemical Journal · doi:10.1042/bj20131618 · Cited by 11
Self-citationIdentification of mutations through dominant screening for obesity using C57BL/6 substrains
Hossain, M. S., Asano, F., Fujiyama, T., Miyoshi, C., Sato, M., Ikkyu, A., Kanno, S., Hotta, N., Kakizaki, M., Honda, T., et al. (2016) · Scientific Reports · doi:10.1038/srep32453 · Cited by 11
RNA m6A Modification: The Mediator Between Cellular Stresses and Biological Effects
Wang, L., Maimaitiyiming, Y., Su, K., & Hsu, C.-H. (2021) · RNA technologies · doi:10.1007/978-3-030-71612-7_13 · Cited by 10
Mandl, M., Viertler, H. P., Zopoglou, M., Mitterberger, M. C., Gasser, J., Hatzmann, F. M., Rauchenwald, T., Zwierzina, M., Mattesich, M., Weiss, A. K. H., et al. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01239-3 · Cited by 10
Identification of new aryl hydrocarbon receptor (AhR) antagonists using a zebrafish model
Jeong, J., Kim, K.-H., Kim, D., Chandrasekaran, G., Kim, M., Pagire, S. H., Dighe, M., Choi, E. Y., Bak, S.-M., Kim, E., et al. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.07.030 · Cited by 10
MAGED 1 is a novel regulator of a select subset of bHLH PAS transcription factors
Sullivan, A. E., Peet, D. J., & Whitelaw, M. L. (2016) · FEBS Journal · doi:10.1111/febs.13824 · Cited by 10
Self-citationVázquez-Gómez, G., Rubio-Lightbourn, J., & Espinosa-Aguirre, J. J. (2016) · TIP Revista Especializada en Ciencias Químico-Biológicas · doi:10.1016/j.recqb.2016.02.006 · Cited by 10
Identification of aryl hydrocarbon receptor allosteric antagonists from clinically approved drugs
Mosa, F. E. S., Alqahtani, M. A., El‐Ghiaty, M. A., Dyck, J. R. B., Barakat, K., & El‐Kadi, A. O. S. (2024) · Drug Development Research · doi:10.1002/ddr.22232 · Cited by 9
Fernández‐Aceñero, M. J., Barderas, R., Peláez‐García, A., Martínez‐Useros, J., Díez-Valladares, L. I., Pérez-Aguirre, Ortega, L. M., la Serna, S. C. D., Botella, A. G., del Arco, C. D., et al. (2021) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2021.151742 · Cited by 9
Ariyeloye, S., Kämmerer, S., Klapproth, E., Wielockx, B., & El‐Armouche, A. (2024) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-024-02921-4 · Cited by 9
Zebrafish as a model for von Hippel Lindau and hypoxia-inducible factor signaling
Kim, H. R., Greenald, D., Vettori, A., Markham, E., Santhakumar, K., Argenton, F., & van Eeden, F. J. M. (2016) · Methods in cell biology · doi:10.1016/bs.mcb.2016.07.001 · Cited by 9
The prospect and underlying mechanisms of Chinese medicine in treating periodontitis
Xing, A., Wang, F., Liu, J., Zhang, Y., He, J., Zhao, B., & Sun, B. (2025) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(25)60842-9 · Cited by 8
Aye, L., Wang, Z., Chen, F., Xiong, Y., Zhou, J., Wu, F., Hu, L., & Wang, D. (2023) · Journal of Immunology Research · doi:10.1155/2023/9946911 · Cited by 8
Dimerization Rules of Mammalian PAS Proteins
Rojas, B. L., Vazquez-Rivera, E., Partch, C. L., & Bradfield, C. A. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168406 · Cited by 8
Veland, N., Gleneadie, H. J., Brown, K. E., Sardini, A., Pombo, J., Dimond, A., Burns, V., Sarkisyan, K. S., Schiering, C., Webster, Z., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06089-6 · Cited by 8
Cooper, A. M., Nutter, C. A., Kuyumcu‐Martinez, M. N., & Wright, C. W. (2022) · Molecular and Cellular Biology · doi:10.1128/mcb.00503-21 · Cited by 8
Kasai, F., Pereira, J. C., Kohara, A., & Ferguson-Smith, M. A. (2018) · DNA Research · doi:10.1093/dnares/dsy007 · Cited by 8
Nakamura, H., Watanabe, M., Takada, K., Sato, T., Hikage, F., Umetsu, A., Muramatsu, J., Furuhashi, M., & Ohguro, H. (2024) · Biomedicines · doi:10.3390/biomedicines12051011 · Cited by 7
Zhang, M., Lv, X., Wang, C., Wang, L., Wang, H., Wang, X., Du, Y., Li, J., Han, X., Fan, L., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1595566 · Cited by 7
Chaubah, M. A. L., Bontes, B. W., & Mulachelah, N. A. (2019) · JSMARTech · doi:10.21776/ub.jsmartech.2019.001.01.3 · Cited by 7
Sequence Analysis and Phylogenetic Studies of Hypoxia-Inducible Factor-1α
Poyya, J., Joshi, C. G., Kumar, D., & Nagendra, H. (2017) · Cancer Informatics · doi:10.1177/1176935117712242 · Cited by 7
In Silico Exploration of AHR-HIF Pathway Interplay: Implications for Therapeutic Targeting in ccRCC
Gregoris, F., Minervini, G., & Tosatto, S. C. E. (2024) · Genes · doi:10.3390/genes15091167 · Cited by 6
A Multicomponent Reaction-Based Platform Opens New Avenues in Aryl Hydrocarbon Receptor Modulation
Rodríguez, P. N., Hartung, F., Pedrola, M., Coomar, S., Diaz-Moreno, A., Hätälä, A. M., Rolfes, K. M., Sánchez‐Vera, I., Gil, J., Molins, E., et al. (2025) · ACS Central Science · doi:10.1021/acscentsci.5c00194 · Cited by 6
Lysyl Oxidase Like-4 (LOXL4) as a tumor marker and prognosticator in advanced stage laryngeal cancer
Altuntaş, O. M., Süslü, N., Tezel, Y. G. G., Doğan, H. T., & Yılmaz, T. (2021) · Brazilian Journal of Otorhinolaryngology · doi:10.1016/j.bjorl.2021.02.009 · Cited by 6
Dysregulation of core circadian genes, BMAL1 and CLOCK, in colorectal cancer
Sahar, N.-E., Qadir, J., Riaz, S. K., Sultan, A., Arif, A., & Malik, M. F. A. (2021) · Biological Rhythm Research · doi:10.1080/09291016.2021.1940623 · Cited by 6
Button, E. L., Rossi, J. J., McDougal, D. P., Bruning, J. B., Peet, D. J., Bersten, D. C., Rosenfeld, J. A., & Whitelaw, M. L. (2022) · Biochemical Journal · doi:10.1042/bcj20220209 · Cited by 6
Self-citationCircadian modulation of glucose utilization via CRY1-mediated repression of Pdk1 expression
Chiou, Y., Lee, C.-Y., Yang, H.-W., Cheng, W., & Ji, K.-D. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.105637 · Cited by 6
Metadata
- Authors
- Bersten, D. C., Sullivan, A. E., Peet, D. J., & Whitelaw, M. L.
- Affiliations
- The University of Adelaide (AU)
- Corresponding author
- Whitelaw, Murray L.
- Venue
- Nature Reviews Cancer
- Published
- 2013-11-22
- Volume
- 13
- Issue
- 12
- Pages
- 827-841
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2011946509
- Cited by
- 267
- References
- 181
- Citations by year
- 2026: 18 · 2025: 18 · 2024: 25 · 2023: 27 · 2022: 25 · 2021: 26 · 2020: 20 · 2019: 17 · 2018: 28 · 2017: 20 · 2016: 19 · 2015: 12 · 2014: 12
- FWCI
- 1.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- bHLH-PAS proteins, helix-loop-helix transcription factors, PAS domain, heterodimeric transcription factors, oncometabolites, cancer metabolism, hypoxia signaling, circadian rhythm, environmental pollutants, protein structure, drug discovery
- MeSH terms
- Animals, Circadian Rhythm, Humans, Neoplasms, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Basic Helix-Loop-Helix Proteins, CLOCK Proteins, Circadian Clocks
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.